Mirvetuximab soravtansine approved to treat adult patients who have ovarian, fallopian tube or primary peritoneal cancer

  • Post author:
  • Post category:

The Medicines and Healthcare products Regulatory Agency (MHRA) has today (24 July 2025) approved the medicine mirvetuximab soravtansine (Elahere) to treat adults with ovarian cancer, fallopian tube cancer, and primary…

Continue ReadingMirvetuximab soravtansine approved to treat adult patients who have ovarian, fallopian tube or primary peritoneal cancer

Innovative ‘collective’ pension funds to deliver higher incomes and lower risks for future pensioners

  • Post author:
  • Post category:

Wide reaching reforms to make innovative “collective” pension funds more commonplace will reduce risk and volatility for savers.Collective Defined Contribution (CDC) schemes pool investment and longevity risks, unlocking productive investment…

Continue ReadingInnovative ‘collective’ pension funds to deliver higher incomes and lower risks for future pensioners